“In silico identification of natural Alzheimer inhibitors targeting GSK-3β using receptor-based pharmacophore and molecular modeling studies” (2025) International Journal of Pharmaceutical Drug Design, 2(5), pp. 102–107. doi:10.62896/ijpdd.2.5.11.